Elanco Animal
Price
Price
Frequently asked questions
What is Elanco Animal's market capitalization?
What is Elanco Animal's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Elanco Animal?
What are the analyst ratings and target price for Elanco Animal's stock?
What is Elanco Animal's revenue over the trailing twelve months?
What is the EBITDA for Elanco Animal?
What is the free cash flow of Elanco Animal?
What is the 5-year beta of Elanco Animal's stock?
How many employees does Elanco Animal have, and what sector and industry does it belong to?
What is the free float of Elanco Animal's shares?
Financials
Market Cap
$6.62B5Y beta
1.42EPS (TTM)
$0.409Free Float
491.10MP/E ratio (TTM)
32.79Revenue (TTM)
$4.45BEBITDA (TTM)
$922.00MFree Cashflow (TTM)
$372.00MPricing
Analyst Ratings
The price target is $19.67 and the stock is covered by 14 analysts.
Buy
8
Hold
5
Sell
1
Information
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
9,300
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker